0001437749-22-021776.txt : 20220902
0001437749-22-021776.hdr.sgml : 20220902
20220902114001
ACCESSION NUMBER: 0001437749-22-021776
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220831
FILED AS OF DATE: 20220902
DATE AS OF CHANGE: 20220902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 221223942
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-08-31
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
General Counsel
Ordinary Shares
2022-08-31
4
M
0
8333
A
15782
D
Ordinary Shares
2022-08-31
4
S
0
3606
7.21
D
12176
D
Restricted Stock Units
2022-08-31
4
M
0
8333
0
D
Ordinary Shares
8333
8334
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023.
/s/ Jason D. Smith, Attorney-in-Fact
2022-09-01